ラリメチニブメシル酸塩 化学特性,用途語,生産方法
効能
抗悪性腫瘍薬, マイトジェン活性化プロテインキナーゼ阻害薬
使用
LY2228820 is a novel and potent p38MAPK inhibitor with potent antiinflammatory activity. LY2228820 significantly inhibited phosphorylation of MAPKAPK2 and/or HSP27, down stream targets of p38MAPK, in both multiple myeloma (MM) cell lines and LT-BMSCs. LY2228820 is a potential candidate to improve MM patient outcome both by enhancing the effect of Bortezomib (B675700) and by reducing osteoskeletal events.
ラリメチニブメシル酸塩 上流と下流の製品情報
原材料
準備製品